Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026

Key Takeaway: Viatris Inc. has announced that it will report its second-quarter 2026 financial results on August 6, 2026. A conference call and live webcast will be held at 8:30 a.m. ET to discuss these results. Investors and the public can access the call via a dedicated website or by phone.
Price reaction · baseline $15.88 (2026-06-30 close) · hit pre-market · clean, no other VTRS news in the window
day 0 close · peak
+1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris is committed to empowering healthier lives globally.
  • The company is actively engaging with investors through a conference call.
  • Viatris has a broad portfolio addressing significant unmet needs.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH,July 1, 2026/PRNewswire/ --Viatris Inc.(Nasdaq:VTRS), a global healthcare company, today announced it will report second-quarter 2026 financial results on Thursday, August 6, 2026. Company executives will host a conference call and live webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call atinvestor.viatris.comor by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About ViatrisViatris Inc.(Nasdaq:VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, China, and Hyderabad, India. Learn more atviatris.comandinvestor.viatris.com, and connect with us onLinkedIn,Instagram,YouTubeandX.

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris report its Q2 2026 financial results?

Viatris will report its Q2 2026 financial results on August 6, 2026.

What time is the Viatris earnings call scheduled?

The Viatris earnings call is scheduled for 8:30 a.m. ET.

How can I listen to the Viatris conference call?

You can listen to the Viatris conference call via a live webcast or by phone.

Where is Viatris headquartered?

Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai, and Hyderabad.

Last updated: Jul 1, 2026